FINE; Jay
Patent Applications and Registrations
Patent applications and USPTO patent grants for FINE; Jay.The latest application filed is for "anti-il-36r antibodies for the treatment of neutrophilic dermatoses".
- FINE; Jay - Mount Kisco NY
- FINE; Jay - Ridgefield CT
- Fine; Jay - Bloomfield NJ
| Patent | Date |
|---|---|
| Anti-il-36r Antibodies For The Treatment Of Neutrophilic Dermatoses App 20220073628 - FINE; Jay ; et al. | 2022-03-10 |
| Antisense Oligonucleotides Targeting Card9 App 20220042011 - FINE; Jay ; et al. | 2022-02-10 |
| Anti-il-36r Antibodies For The Treatment Of Atopic Dermatitis App 20220010022 - FLACK; Mary Ruth ; et al. | 2022-01-13 |
| Thiadiazoles As Cxc- And Cc- Chemokine Receptor Ligands App 20080090823 - Biju; Purakkattle J. ; et al. | 2008-04-17 |
| Cxcr1 And Cxcr2 Chemokine Antagonists App 20070248594 - Chao; Jianhua ; et al. | 2007-10-25 |
| Thiadiazoles AS CXC- and CC- chemokine receptor ligands App 20060223864 - Biju; Purakkattle J. ; et al. | 2006-10-05 |
| Isothiazole dioxides as CXC- and CC-chemokine receptor ligands App 20060025453 - Taveras; Arthur G. ; et al. | 2006-02-02 |
| CXCR1 and CXCR2 chemokine antagonists App 20060014794 - Chao; Jianhua ; et al. | 2006-01-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 